Pericardiocentesis and intrapericardial sclerosis: Effective therapy for malignant pericardial effusions

Annals of Thoracic Surgery

Volumn 64, Issue 5, 1997, Pages 1422-1428

  Girardi, Leonard N ^a   Ginsberg, Robert J ^a   Burt, Michael E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HUMAN; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; SCLEROTHERAPY; THYMOMA; TREATMENT PLANNING;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DRAINAGE; ENDOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PARACENTESIS; PERICARDIAL EFFUSION; PERICARDIAL WINDOW TECHNIQUES; PERICARDIECTOMY; RECURRENCE; RETROSPECTIVE STUDIES; SCLEROTHERAPY; SURVIVAL RATE; THIOTEPA; THORACOSCOPY;

EID: 0030731008     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00992-2     Document Type: Article

References (23)

1. Bisel HF, Wroblewski F, LaDue JS. Incidence and clinical manifestations of cardiac metastases. JAMA 1953;153:712-5.
2. Press OW, Livingstone R. Management of malignant pericardial effusion and tamponade. JAMA 1987;257:1088-92.
3. Schuh F. Erfahrungen uber die paracentese der brust und des herzbeutels. Med Jahrb Osterstaates Wein (Neuste Folge 24) 1841;33:388.
4. Park JS, Rentschler R, Wilbur D. Surgical management of pericardial effusion in patients with malignancies. Cancer 1991;67:76-80.
5. Hankins JR, Saterfield JR, Aisner J, Wiernik PH, McLaughlin JS. Pericardial window for malignant pericardial effusion. Ann Thorac Surg 1980;30:465-71.
6. Campbell PT, Van Trigt P, Wall TC, et al Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy. Chest 1992;101:938-43.
7. Moores DWO, Allen KB, Faber LP, et al. Subxiphoid pericardial drainage for pericardial tamponade. J Thorac Cardiovase Surg 1995;109:546-52.
8. Hazelrigg SR, Mack MJ, Landreneau RJ, Acuff TE, Seifert PE, Auer JE. Thoracoscopic pericardiectomy for effusive pericardial disease. Ann Thorac Surg 1993;56:792-5.
9. Mack MJ, Landreneau RJ, Hazelrigg SR, Acuff TE. Video thoracoscopic management of benign and malignant pericardial effusions. Chest 1993;103:390S-3S.
10. Wang N, Geikes R, Mogensen BS, Vyhmeister EE, Bailey LL. Pericardioperitoneal shunt: an alternative treatment for malignant pericardial effusion. Ann Thorac Surg 1994;57:289-92.
11. Maher HJ. Transdiaphragmatic pericardial window: a new approach. J Cardiovasc Surg 1993;34:173-5.
12. Ziskind AA, Rodriguiz S, Lemmons CC, et al. Percutaneous balloon pericardiotomy for the treatment of effusive pericardial disease: 104 patient follow-up [Abstract]. J Am Coll Cardiol 1994;274A-5A.
13. Liu HP, Chang CH, Lin PJ, Hsieh HC, Chang JP, Hsieh MJ. Thoracoscopic management of effusive pericardial disease: indications and treatment. Ann Thorac Surg 1994;58:1965-7.
14. Daley JR, Seward JB, Schmidt L, Sinak LJ, Callahan JA, Tajik AJ. Management of malignant pericardial effusions: the role of 2-D echo-directed pericardiocentesis and catheter drainage [Abstract]. J Am Coll Cardiol 1992;19:357A.
15. Celermajer DS, Boyer MJ, Bailey BP, Tattersall MHN. Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients. Med J Aust 1991;154:19-22.
16. Liu G, Crump M, GOSS PE, Dancey J, Shepherd FA. Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol 1996;14:3141-7.
17. Maher EA, Shepherd FA, Todd TJR. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996;112:637-43.
18. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Wong B, Murphy J, Chang CJ, Hassenein K, Dunn M. The risk of pericardiocentesis. Am J Cardiol 1979;44:1110-4.
20. Vaitkus PT, Hermann HC, LeWinter MM. Treatment of malignant pericardial effusion. JAMA 1994;272:59-64.
21. Mills SA, Julian S, Holliday PAC, et al. Subxiphoid pericardial window for pericardial effusive disease. J Cardiovasc Surg 1989;768-73.
22. Okamoto H, Shinkai T, Yamakido M. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer 1993;71:93-8.
23. Sugimoto JT, Little AG, Ferguson MK, et al. Pericardial window: mechanisms of efficacy. Ann Thorac Surg 1990;50:442-5.